BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19438743)

  • 41. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells.
    Shrivastav A; Varma S; Senger A; Khandelwal RL; Carlsen S; Sharma RK
    J Pathol; 2009 Jul; 218(3):391-8. PubMed ID: 19360752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of NKX3.1 in normal and malignant tissues.
    Gelmann EP; Bowen C; Bubendorf L
    Prostate; 2003 May; 55(2):111-7. PubMed ID: 12661036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor.
    Surowiak P; Murawa D; Materna V; Maciejczyk A; Pudelko M; Ciesla S; Breborowicz J; Murawa P; Zabel M; Dietel M; Lage H
    Anticancer Res; 2007; 27(4C):2917-24. PubMed ID: 17695471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COX-2 expression does not correlate with microvessel density in breast cancer.
    Thorat MA; Mehrotra S; Morimiya A; Badve S
    Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer.
    Kanojia D; Garg M; Gupta S; Gupta A; Suri A
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):630-9. PubMed ID: 19190149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. E-cadherin expression in invasive breast cancer.
    Suciu C; Cîmpean AM; Mureşan AM; Izvernariu D; Raica M
    Rom J Morphol Embryol; 2008; 49(4):517-23. PubMed ID: 19050801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of HAb18G/CD147 knockout on hepatocellular carcinoma cells in vitro using a novel zinc-finger nuclease-targeted gene knockout approach.
    Li HW; Yang XM; Tang J; Wang SJ; Chen ZN; Jiang JL
    Cell Biochem Biophys; 2015 Mar; 71(2):881-90. PubMed ID: 25308857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lineage infidelity and expression of melanocytic markers in human breast cancer.
    Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
    Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.
    Al-Bazz YO; Underwood JC; Brown BL; Dobson PR
    Eur J Cancer; 2009 Mar; 45(4):694-704. PubMed ID: 19138840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients.
    Wiesner FG; Magener A; Fasching PA; Wesse J; Bani MR; Rauh C; Jud S; Schrauder M; Loehberg CR; Beckmann MW; Hartmann A; Lux MP
    Breast; 2009 Apr; 18(2):135-41. PubMed ID: 19342238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Histopathologic diagnosis of luminal and basal type breast cancer].
    Sarcević B
    Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues.
    Othman MI; Majid MI; Singh M; Man CN; Lay-Harn G
    Ann Clin Biochem; 2008 May; 45(Pt 3):299-306. PubMed ID: 18482919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD24 expression has a prognostic impact in breast carcinoma.
    Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
    Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of matrix metalloproteinase production and tumor cell invasion by four monoclonal antibodies against different epitopes of HAb18G/CD147 extracellular domain.
    Wang L; Ku XM; Li Y; Bian HJ; Zhang SH; Ye H; Yao XY; Li BH; Yang XM; Liao CG; Chen ZN
    Hybridoma (Larchmt); 2006 Apr; 25(2):60-7. PubMed ID: 16704305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z; Huang H; Li H; Chen W; Pan C
    J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Quantitative immunohistochemical tenascin test in infiltrative duct breast cancer].
    Zavalishina LE; Petrov AN; Andreeva IuIu
    Arkh Patol; 2005; 67(6):21-4. PubMed ID: 16405016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
    J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteopontin expression correlates with invasiveness in cervical cancer.
    Song JY; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):434-8. PubMed ID: 19694703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer.
    Likui W; Qun L; Wanqing Z; Haifeng S; Fangqiu L; Xiaojun L
    J Surg Oncol; 2009 Oct; 100(5):396-400. PubMed ID: 19582795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells.
    Mandeville JA; Silva Neto B; Vanni AJ; Smith GL; Rieger-Christ KM; Zeheb R; Loda M; Libertino JA; Summerhayes IC
    BJU Int; 2008 Dec; 102(11):1707-14. PubMed ID: 18990147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.